TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.28 CNY | -0.33% |
|
-4.38% | -6.77% |
| Sales 2024 * | 2.76B 381M | Sales 2025 * | 3.22B 444M | Capitalization | 7.07B 976M |
|---|---|---|---|---|---|
| Net income 2024 * | 530M 73.19M | Net income 2025 * | 612M 84.52M | EV / Sales 2024 * | 2.86 x |
| Net Debt 2024 * | 820M 113M | Net Debt 2025 * | 874M 121M | EV / Sales 2025 * | 2.47 x |
| P/E ratio 2024 * |
13.5
x | P/E ratio 2025 * |
11.7
x | Employees | 2,496 |
| Yield 2024 * |
2.73% | Yield 2025 * |
3.22% | Free-Float | 51.79% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.33% | ||
| 1 week | -4.38% | ||
| 1 month | -6.77% | ||
| 3 months | +3.38% | ||
| 6 months | -11.93% | ||
| Current year | -6.77% |
1 week
15.21
16.06
1 month
15.2118.66
Current year
11.5518.66
1 year
11.5519.19
3 years
11.5544.41
5 years
10.7144.41
10 years
6.3044.41
| Managers | Title | Age | Since |
|---|---|---|---|
Shou Jun Li
CEO | Chief Executive Officer | 61 | 98-08-02 |
Chang Chang Li
DFI | Director of Finance/CFO | 49 | 22-04-27 |
Xiu Tong Zhu
BRD | Director/Board Member | 43 | 20-10-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shou Jun Li
CEO | Chief Executive Officer | 61 | 98-08-02 |
Zhong Hua Zhou
CHM | Chairman | 61 | 18-12-23 |
Lei Xu
BRD | Director/Board Member | 51 | 19-12-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 15.28 | -0.33% | 3,331,615 |
| 24-05-30 | 15.33 | -0.90% | 2,628,849 |
| 24-05-29 | 15.47 | -0.39% | 3,376,305 |
| 24-05-28 | 15.53 | -2.51% | 4,461,178 |
| 24-05-27 | 15.93 | -0.31% | 6,716,505 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotes
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
15.28
CNY
Average target price
21.14
CNY
Spread / Average Target
+38.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.77% | 976M | |
| +18.66% | 8.74B | |
| +23.75% | 3.67B | |
| -0.42% | 3.25B | |
| +18.07% | 1.73B | |
| -16.99% | 1.38B | |
| -0.39% | 1.31B | |
| -26.05% | 1.24B | |
| -17.86% | 1.07B | |
| -2.89% | 892M |
- Stock Market
- Equities
- 300119 Stock
